You are here

FDA Approves Bio Products Laboratory’s Gammaplex 10% for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura

CLICK HERE to read the press release from Bio Products Laboratory Limited (BPL) regarding the recent FDA approval of Gammaplex® 10%.

News Category: